Cbdmd Inc Stock Alpha and Beta Analysis

YCBD Stock  USD 0.47  0.01  2.17%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as cbdMD Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in CbdMD over a specified time horizon. Remember, high CbdMD's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to CbdMD's market risk premium analysis include:
Beta
(0.98)
Alpha
(0.06)
Risk
4.64
Sharpe Ratio
(0.01)
Expected Return
(0.06)
Please note that although CbdMD alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, CbdMD did 0.06  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of cbdMD Inc stock's relative risk over its benchmark. cbdMD Inc has a beta of 0.98  . As the market becomes more bullish, returns on owning CbdMD are expected to decrease slowly. On the other hand, during market turmoil, CbdMD is expected to outperform it slightly. The current year's Tangible Book Value Per Share is expected to grow to 2.72, whereas Book Value Per Share is forecasted to decline to 3.82.

Enterprise Value

4.34 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out CbdMD Backtesting, CbdMD Valuation, CbdMD Correlation, CbdMD Hype Analysis, CbdMD Volatility, CbdMD History and analyze CbdMD Performance.

CbdMD Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. CbdMD market risk premium is the additional return an investor will receive from holding CbdMD long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CbdMD. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate CbdMD's performance over market.
α-0.06   β-0.98

CbdMD expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of CbdMD's Buy-and-hold return. Our buy-and-hold chart shows how CbdMD performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

CbdMD Market Price Analysis

Market price analysis indicators help investors to evaluate how CbdMD stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CbdMD shares will generate the highest return on investment. By understating and applying CbdMD stock market price indicators, traders can identify CbdMD position entry and exit signals to maximize returns.

CbdMD Return and Market Media

The median price of CbdMD for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 0.48 with a coefficient of variation of 8.29. The daily time series for the period is distributed with a sample standard deviation of 0.04, arithmetic mean of 0.49, and mean deviation of 0.04. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Kennedy Thomas Ronan of 38465 shares of CbdMD at 270.0 subject to Rule 16b-3
09/23/2024
2
Acquisition by Kennedy Thomas Ronan of 1000 shares of CbdMD at 270.0 subject to Rule 16b-3
09/26/2024
3
Acquisition by Kennedy Thomas Ronan of 16667 shares of CbdMD subject to Rule 16b-3
10/14/2024
4
cbdMD Launches THC Seltzers in 4B Market Push with Fast-Acting Technology YCBD Stock News - StockTitan
11/14/2024

About CbdMD Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including CbdMD or other stocks. Alpha measures the amount that position in cbdMD Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.31.761.591.66
Price To Sales Ratio0.380.08620.09920.0942

CbdMD Upcoming Company Events

As portrayed in its financial statements, the presentation of CbdMD's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CbdMD's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of CbdMD's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of CbdMD. Please utilize our Beneish M Score to check the likelihood of CbdMD's management manipulating its earnings.
12th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with CbdMD

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:
Check out CbdMD Backtesting, CbdMD Valuation, CbdMD Correlation, CbdMD Hype Analysis, CbdMD Volatility, CbdMD History and analyze CbdMD Performance.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
CbdMD technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CbdMD technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CbdMD trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...